Lisa Rometty
Equibles does not estimate personal net worth.
Get an email with a short summary when Rani Therapeutics Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get RANI alertsAbout Lisa Rometty
Lisa Rometty is recorded as CEO at Rani Therapeutics Holdings, Inc. (RANI). The newest filing on record that lists Lisa Rometty as CEO at Rani Therapeutics Holdings, Inc. (RANI) is dated April 16, 2026. Rani Therapeutics Holdings, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rani Therapeutics Holdings, Inc. includes Talat Imran (CEO and Board Member), Mir Imran (Chairman), Nicholas M. Maestas (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 16, 2026
-
Rani Therapeutics Holdings, Inc. (RANI)
Proxy statement
Start not stated–2022-04-13
Last confirmed by a filing; no departure on record
-
Start not stated–2023-04-11
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Rani Therapeutics Holdings, Inc.
- Talat Imran CEO, Board Member
- Mir Imran Chairman
- Nicholas M. Maestas CFO
- Lyn Baranowski COO, Board Member
- Eric Groen General Counsel
- Abraham Bassan Board Member
- Dennis Ausiello Board Member
- Jean-Luc Butel Board Member
- Michelle Gilson Board Member
- Vasudev Bailey Board Member
Recent activity
No call appearances or filed executive changes recorded yet.